{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:18:31Z","timestamp":1761801511331,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: The American Society of Clinical Oncology (ASCO) established recommendations for palliative care (PC), and they still remain the most trusted source overall. The standard published by C. Earle (defined in solid tumors) for referral to PC is &gt; 55%. However, these rates remain unclear in general onco-hematology. Our referral rate reaches 60%; while it meets the standard, there are significant differences between ST and HM. Several authors have already pointed out these discrepancies. Arguing in some cases its possible relationship with the different behavior of professionals with different pathologies. Objective: The primary objective of this work is to understand the role that PC plays in onco-hematology and to determine the profile of patients referred to PC. Therefore, the article aims to establish some recommendations related to the results of prevalent characteristics. Methods: The Mortality Subcommittee (MS) includes and registers in a database all cancer patients who died in hospital undergoing systemic anticancer therapy (SACT) in their last 30 days of life (SACT \u2264 30 d). PC, in turn, works on relieving symptoms related to the disease and the patient. To understand the impact of PC in the MS database patients, we reviewed the literature for symptoms related to palliative care activity. Subsequently, we selected some signs and symptoms, by consensus with our PC specialists, in order to add them to the MS database and register them retrospectively. We measured the percentage of patients who registered these symptoms based on the data found in their electronic records. The results include the comparison by group: between patients referred or not to the PC program (PCP), and between the pathologies ST and HM. We used the programming language R (version 4.2) in our statistical analysis, including the \u201ccompareGroups\u201d package (version 4.6), applying the pertinent tests based on the distribution of the data. Results: We completed the records on the 1681 patients from the period 2020\u20132023. 59.4% were men, the average age was 65.5 years, and 73.5% had ST and 26.5% had HM. Patients with lung cancer predominate (28.5%), with 71% of them being in the stage IV, followed by leukemia (9.76%). 60% are in progression of their disease, and 77% have advanced disease (AD). The average therapeutic aggressiveness indicators were SACT &lt; 30 d: 38.9% (ST: 33.4%; HM: 70.97%); SACT &lt; 14 d: 16.36% (ST: 13.76%; HM: 31.56%); the change in therapeutic regimen was 22% (ST: 20.8%; HM: 25.1%). The referral rate to PCP was 59.7% (ST: 68.2% and HM: 36.3%). Late referral (PCP \u22643 days before death) occurred in 29.2% of all patients, being 29% for ST cases and 30.4% for HM cases. Regarding the recording of signs and symptoms: psycho-emotional and analgesia regimens (including opioids) are better recorded in the PCP group (p &lt; 0.001); the more physical symptoms (dyspnea, bleeding, infections, and severe symptoms) do not present statistically significant differences, although the severe symptoms in the PCP group are more disabling (cerebral involvement, spinal cord compression, vertebral crushing). The number of bags of blood products transfused is significantly lower in the PCP group (average 6.9 vs. 12.7). The total number of symptom variables with significant statistical differences was 13 for ST and 8 for HM. Conclusions: In this cohort, patients visited by PC had a better record of psycho-emotional symptoms. We consider that patients who are in any of the following situations should be referred to PC: initial diagnosis of stage IV lung cancer, leukemia; patients with advanced disease; presence of pain requiring opioids; psychoemotional symptoms; need for &gt;7 to 15 transfusions of blood products and, if there are disabling symptoms. PC improves professional interest in the psycho-emotional and fragility situation of these patients. According to our data (in terms of the number of variables with significant differences by pathology group), we observed that hematologists tend to take on palliative tasks more frequently than their oncologist peers, who delegate them to PC in order to have more time dedicated to their specific field.<\/jats:p>","DOI":"10.3390\/cancers17213467","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:02:01Z","timestamp":1761670921000},"page":"3467","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Palliative Care in Onco-Hematology Retrospective Observational Cohort Study in Deceased In-Hospital Patients with SACT at the End of Life: Experience with Real-World Data from a Cancer Monographic Institution"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4437-6468","authenticated-orcid":false,"given":"Lourdes","family":"P\u00e9triz","sequence":"first","affiliation":[{"name":"Strategy and Quality Department, Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Asensio","sequence":"additional","affiliation":[{"name":"Strategy and Quality Department, Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3240-4408","authenticated-orcid":false,"given":"Eva","family":"Loureiro","sequence":"additional","affiliation":[{"name":"Computer Systems Service, Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0024-3800","authenticated-orcid":false,"given":"Joan","family":"Muniesa","sequence":"additional","affiliation":[{"name":"Computer Systems Service, Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gala","family":"Serrano","sequence":"additional","affiliation":[{"name":"Palliative Care Department, Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarsila","family":"Ferro","sequence":"additional","affiliation":[{"name":"Strategy and Quality Department, Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat, 08908 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/OP.24.00225","article-title":"Palliative Care for Patients With Cancer: ASCO Guideline Clinical Insights","volume":"20","author":"Ferrell","year":"2024","journal-title":"JCO Oncol. Pract."},{"key":"ref_3","unstructured":"WHO (2025, July 01). Definition of Palliative Care, Available online: https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/palliative-care."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","article-title":"Alleviating the access abyss in palliative care and pain relief\u2014An imperative of universal health coverage: The Lancet Commission report","volume":"391","author":"Knaul","year":"2018","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jpainsymman.2020.04.027","article-title":"Redefining Palliative Care\u2014A New Consensus-Based Definition","volume":"60","author":"Radbruch","year":"2020","journal-title":"J. Pain Symptom Manag."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/jpm.2020.0597","article-title":"A Palliative Care Intervention for Patients on Phase 1 Studies","volume":"24","author":"Ferrell","year":"2021","journal-title":"J. Palliat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"pkaa067","DOI":"10.1093\/jncics\/pkaa067","article-title":"Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials","volume":"4","author":"Sedhom","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1200\/JCO.2003.03.059","article-title":"Identifying potential indicators of the quality of end-of-life cancer care from administrative data","volume":"21","author":"Earle","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1200\/JCO.2004.08.136","article-title":"Trends in the aggressiveness of cancer care near the end of life","volume":"22","author":"Earle","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intqhc\/mzi061","article-title":"Evaluating claims-based indicators of the intensity of end-of-life cancer care","volume":"17","author":"Earle","year":"2005","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/cncr.28614","article-title":"Quality of end-of-life care in patients with hematologic malignancies: A retrospective cohort study","volume":"120","author":"Hui","year":"2014","journal-title":"Cancer"},{"key":"ref_13","first-page":"1973","article-title":"Prognostication in advanced cancer: Update and directions for future research","volume":"27","author":"Hui","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_14","first-page":"71","article-title":"La agresividad terap\u00e9utica y la oncolog\u00eda l\u00edquida. Therapeutic ag-gressiveness and liquid oncology","volume":"28","year":"2017","journal-title":"Cuad. Bioet."},{"key":"ref_15","first-page":"101160","article-title":"A retrospective cohort study of onco-hematologic inpatients with SACT at the end of life in a single cancer institution: Differences between solid tumors and hematological neoplasms","volume":"41","author":"Vidal","year":"2025","journal-title":"J. Health Qual. Res."},{"key":"ref_16","unstructured":"P\u00e9triz, L., Asensio, E., Muniesa, J., Briculle, R., Serrano, G., and Ferro, T. (2023, January 25). Estudio de variables para mejorar los indicadores y su disponibilidad en relacion a la participaci\u00f3n de cuidados paliativos en onco-hematologia. (Study of variables to im-prove the indicators and their availability in relation to the participation of palliative care in onco-hematology). Proceedings of the Communication to SECA congress: XXXIX Congreso de la Sociedad Espa\u00f1ola de Calidad Asistencial, Murcia, Spain."},{"key":"ref_17","first-page":"e746","article-title":"Palliative care of patients with haematological malignancies: Strategies to overcome difficulties via integrated care","volume":"2","author":"Wedding","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1445-5994.2003.00490.x","article-title":"Australasian haematologist referral patterns to palliative care: Lack of consensus on when and why","volume":"33","author":"Auret","year":"2003","journal-title":"Intern. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.30735","article-title":"Why are patients with blood cancers more likely to die without hospice?","volume":"123","author":"Odejide","year":"2017","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/asheducation-2015.1.471","article-title":"When and why should patients with hematologic malignancies see a palliative care specialist?","volume":"2015","author":"LeBlanc","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"McCaughan, D., Roman, E., Smith, A.G., Garry, A.C., Johnson, M.J., Patmore, R.D., Howard, M.R., and Howell, D.A. (2018). Palliative care specialists\u2019 perceptions concerning referral of haematology patients to their services: Findings from a qualitative study. BMC Palliat. Care, 17.","DOI":"10.1186\/s12904-018-0289-1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpainsymman.2017.08.030","article-title":"Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies","volume":"55","author":"Hochman","year":"2018","journal-title":"J. Pain Symptom Manag."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jama.2009.1198","article-title":"Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial","volume":"302","author":"Bakitas","year":"2009","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"dju129","DOI":"10.1093\/jnci\/dju129","article-title":"Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials","volume":"106","author":"Reeve","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00277-013-1861-7","article-title":"Patients with malignant hematological disorders treated on a palliative care unit: Prognostic impact of clinical factors","volume":"93","author":"Kripp","year":"2013","journal-title":"Ann. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","article-title":"Health related quality of life in a nationally representative sample of haematological patients","volume":"83","author":"Johnsen","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_27","first-page":"79","article-title":"Palliative care in patients with haematological neoplasms: An integrative systematic review","volume":"32","year":"2017","journal-title":"Palliat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1532-5415.1987.tb01341.x","article-title":"A Quantitative analysis of palliative care decisions in acute nonlymphocytic leukemia","volume":"35","author":"Neuss","year":"1987","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v057.i12","article-title":"Building Bivariate Tables: The compareGroups Package for R","volume":"57","author":"Subirana","year":"2014","journal-title":"J. Stat. Softw."},{"key":"ref_30","unstructured":"Subirana, I., Sanz, H., Vila, J., Lucas, G., and Gim\u00e9nez, D. (2025, August 19). CompareGroups: Descriptive Analysis by Group\u2019s Package. Version 4.2.0. Available online: https:\/\/CRAN.R-project.org\/package=compareGroups."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.regg.2018.01.003","article-title":"Protocolo territorial de adecuaci\u00f3n de la intensidad terap\u00e9utica. \u00c1rea Metropolitana Sur de Barcelona","volume":"53","author":"Ugarte","year":"2018","journal-title":"Rev. Esp. Geriatr. Gerontol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/annonc\/mdv028","article-title":"Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists","volume":"26","author":"Hui","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cncr.32549","article-title":"Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization","volume":"126","author":"Odejide","year":"2019","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00432-024-05721-6","article-title":"Utilization and quality of palliative care in patients with hematological and solid cancers: A population-based study","volume":"150","author":"Gebel","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_35","first-page":"445","article-title":"Knowledge, feelings, and willingness to use palliative care in cancer patients with hematologic malignancies and solid tumors: A prospective, cross-sectional study in a comprehensive cancer center in Germany","volume":"31","author":"Gebel","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2014.58.6362","article-title":"Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial","volume":"33","author":"Bakitas","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1200\/JCO.18.02386","article-title":"Palliative and End-of-Life Care for Patients With Hematologic Malignancies","volume":"38","author":"Nelson","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbmt.2019.09.006","article-title":"Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation","volume":"26","author":"Kongtim","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jpainsymman.2021.03.014","article-title":"Outcomes of Specialty Palliative Care Interventions for Patients With Hematologic Malignancies: A Systematic Review","volume":"62","author":"Elliott","year":"2021","journal-title":"J. Pain Symptom Manag."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/21\/3467\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:13:33Z","timestamp":1761801213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/21\/3467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":39,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["cancers17213467"],"URL":"https:\/\/doi.org\/10.3390\/cancers17213467","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}